Death Studies ( IF 4.340 ) Pub Date : 2022-04-20 , DOI: 10.1080/07481187.2022.2063456 Caroline Variath 1 , Seth A Climans 2 , Kim Edelstein 3, 4 , Jennifer A H Bell 3, 4, 5
Abstract
In most jurisdictions where medical assistance in dying (MAiD) is legal, patients must have decision-making capacity. Brain cancer often damages the cognitive networks required to maintain decision-making capacity. Using qualitative methodology guided by a relational ethics conceptual framework, this study explored neuro-oncology clinicians’ perspectives on access to and eligibility for MAiD for patients diagnosed with brain cancer. We interviewed 24 neuro-oncology clinicians from 6 countries. Participants described the unique challenges facing brain cancer patients, potentially resulting in their inequitable access to MAiD. The findings highlight the importance of early end-of-life conversations, advance care planning, and access to end-of-life treatment options.
中文翻译:
神经肿瘤学临床医生对影响脑癌患者获得临终医疗救助的因素的看法:一项定性研究
摘要
在大多数临终医疗救助 (MAiD) 合法的司法管辖区,患者必须具有决策能力。脑癌通常会损害维持决策能力所需的认知网络。本研究使用以关系伦理概念框架为指导的定性方法,探讨了神经肿瘤学临床医生对诊断为脑癌的患者获得 MAiD 的机会和资格的看法。我们采访了来自 6 个国家的 24 位神经肿瘤学临床医生。参与者描述了脑癌患者面临的独特挑战,这可能导致他们无法公平地获得 MAiD。研究结果强调了早期临终对话、预先护理计划和获得临终治疗选择的重要性。